Welcome to the European Neuroendocrine Tumor Society

Founded in 2004, ENETS is the leading and longest-established society dedicated to improving the diagnosis and treatment of neuroendocrine tumours (NETs). With over 1,500 members, ENETS brings together experts in oncology, endocrinology, gastroenterology, nuclear medicine, pathology, radiology, surgery, and basic and translational science.

Our mission is to raise awareness, advance research and foster collaboration to improve the care of patients with neuroendocrine tumours.

Through accredited educational programmes, conferences, webinars and e-learning, ENETS supports healthcare professionals across Europe and beyond in advancing knowledge and clinical practice.

EBNENM Exams 2027

Applications are now open! The EBNENM examinations will take place from 10–12 March in Milan, Italy, as part of the ENETS Annual Conference.

Application deadline: 30 November 2026

Learn more and apply

ENETS Publications

New ENETS Guidance Paper

The ninth ENETS guidance paper provides evidence-graded recommendations for the diagnosis and management of lung and thymic carcinoids. Published open access in the Journal of Neuroendocrinology.

Explore ENETS guidelines

NENs Policy Recommendations

At the 2024 ENETS Annual Conference, a roundtable discussion brought together physicians, patients and EU policymakers to address key barriers to improving NEN care across Europe.

Read recommendations

Controversies in NEN

A new ENETS position statement explores liver transplantation in advanced small-intestinal and pancreatic NETs, offering expert consensus on patient selection, benefits and risks. Published open access in JNE.

Explore consensus papers

BS & TS Task Force Whitepaper

The ENETS Basic and Translational Science Task Force outlines best practices for translational research in neuroendocrine neoplasms in its new whitepaper. Published in the Journal of Neuroendocrinology.

Read the whitepaper

SSTR-PeRForm

Published in The Lancet Oncology, this ENETS-led framework, endorsed by EANM and NANETS, introduces standardised criteria for assessing treatment response using somatostatin receptor (SSTR) PET in patients with NETs, supporting consistent response evaluation in clinical practice.

Read the abstract

MEN1 Task Force Study

Published in the Journal of Neuroendocrinology, this ENETS Task Force study examines screening and surveillance practices for MEN1-related neuroendocrine tumours across ENETS Centers of Excellence.

Read the study

ENETS Newsletter

View all newsletters

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.

Learn more

Support ENETS

Any donation made to ENETS charity, no matter what size, will help to support us with our many projects. ENETS wants to ensure that neuroendocrine cancer patients in Europe get a timely diagnosis, the best level of care and ultimately, a cure. Click below to read more.

Donate now

ENETS FACTS

24 Annual Conferences
Since 2004
3 Hybrid conferences from 2022 - 2024
5 Virtual conferences
between 2020 - 2024
1,610 Currently registered members